Geode Capital Management LLC Boosts Stake in Seer, Inc. (NASDAQ:SEER)

Geode Capital Management LLC raised its position in Seer, Inc. (NASDAQ:SEER) by 5.9% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 446,329 shares of the company’s stock after purchasing an additional 25,002 shares during the period. Geode Capital Management LLC’s holdings in Seer were worth $879,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. AQR Capital Management LLC acquired a new stake in shares of Seer in the 2nd quarter valued at about $30,000. Point72 DIFC Ltd acquired a new stake in Seer during the second quarter worth about $35,000. American Century Companies Inc. raised its stake in Seer by 42.1% during the second quarter. American Century Companies Inc. now owns 61,752 shares of the company’s stock worth $104,000 after acquiring an additional 18,302 shares during the period. Quadrature Capital Ltd raised its stake in Seer by 301.7% during the third quarter. Quadrature Capital Ltd now owns 57,088 shares of the company’s stock worth $112,000 after acquiring an additional 42,875 shares during the period. Finally, XTX Topco Ltd acquired a new stake in Seer during the third quarter worth about $123,000. 75.20% of the stock is owned by hedge funds and other institutional investors.

Seer Trading Down 0.4 %

Shares of NASDAQ:SEER opened at $2.40 on Friday. The firm’s 50 day moving average is $2.36 and its two-hundred day moving average is $1.99. Seer, Inc. has a 52 week low of $1.51 and a 52 week high of $2.63. The firm has a market capitalization of $141.52 million, a P/E ratio of -1.85 and a beta of 1.57.

Seer Profile

Seer, Inc, a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.